Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 687-695

  Andoh, Akira ^a   Shioya, Makoto ^a   Nishida, Atsushi ^a   Bamba, Shigeki ^a   Tsujikawa, Tomoyuki ^a   Kim Mitsuyama, Shokei ^b   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INTERLEUKIN 1BETA; INTERLEUKIN 24; JANUS KINASE 1; MUCIN 1; MUCIN 3; MUCIN 4; SALICYLIC ACID; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR AP 1; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; JAK1 PROTEIN, HUMAN; MUCIN; SOCS3 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; ULCERATIVE COLITIS; BIOSYNTHESIS; CELL LINE; CELL STRAIN CACO 2; CELL STRAIN HT29; COLON; ENTERITIS; FIBROBLAST; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; UPREGULATION;

CACO-2 CELLS; CELL LINE; COLON; FIBROBLASTS; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; INTESTINAL MUCOSA; JANUS KINASE 1; MAP KINASE SIGNALING SYSTEM; MUCINS; MUSCLE, SMOOTH; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 68949122797     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804169     Document Type: Article

References (65)

1. Sands, B. E. 2007. Inflammatory bowel disease: past, present, and future. J. Gastroenterol. 42: 16-25.
2. Mizoguchi, A., and E. Mizoguchi. 2008. Inflammatory bowel disease, past, present and future: lessons from animal models. J. Gastroenterol. 43: 1-17.
3. Jiang, H., J. J. Lin, Z. Z. Su, N. I. Goldstein, and P. B. Fisher. 1995. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486.
4. Langer, J. A., E. C. Cutrone, and S. Kotenko. 2004. The class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev. 15: 33-48.
5. Caudell, E. G., J. B. Mumm, N. Poindexter, S. Ekmekcioglu, A. M. Mhashilkar, X. H. Yang, M. W. Retter, P. Hill, S. Chada, and E. A. Grimm. 2002. The protein product of the tumor suppressor gene, melanoma differentiation- associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 168: 6041-6046.
6. Huang, E. Y., M. T. Madireddi, R. V. Gopalkrishnan, M. Leszczyniecka, Z. Su, I. V. Lebedeva, D. Kang, H. Jiang, J. J. Lin, D. Alexandre, et al. 2001. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20: 7051-7063.
7. Wang, M., Z. Tan, R. Zhang, S. V. Kotenko, and P. Liang. 2002. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem. 277: 7341-7347.
8. Wang, M., and P. Liang. 2005. Interleukin-24 and its receptors. Immunology 114: 166-170.
9. Dumoutier, L., C. Leemans, D. Lejeune, S. V. Kotenko, and J. C. Renauld. 2001. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167: 3545-3549. (Pubitemid 32910793)
10. Dumoutier, L., and J. C. Renauld. 2002. Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur. Cytokine Netw. 13: 5-15. (Pubitemid 34535567)
11. Nagalakshmi, M. L., E. Murphy, T. McClanahan, and R. de Waal Malefyt. 2004. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int. Immunopharmacol. 4: 577-592.
12. Kunz, S., K. Wolk, E. Witte, K. Witte, W. D. Doecke, H. D. Volk, W. Sterry, K. Asadullah, and R. Sabat. 2006. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp. Dermatol. 15: 991-1004.
13. Wolk, K., S. Kunz, K. Asadullah, and R. Sabat. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168: 5397-5402.
14. Su, Z., L. Emdad, M. Sauane, I. V. Lebedeva, D. Sarkar, P. Gupta, C. D. James, A. Randolph, K. Valerie, M. R. Walter, P. Dent, and P. B. Fisher. 2005. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene 24: 7552-7566.
15. Kreis, S., D. Philippidou, C. Margue, and I. Behrmann. 2008. IL-24: a classic cytokine and/or a potential cure for cancer? J. Cell Mol. Med. 12: 2505-2510.
16. Kreis, S., D. Philippidou, C. Margue, C. Rolvering, C. Haan, L. Dumoutier, J. C. Renauld, and I. Behrmann. 2007. Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS ONE. 2: e1300.
17. Gupta, P., Z. Z. Su, I. V. Lebedeva, D. Sarkar, M. Sauane, L. Emdad, M. A. Bachelor, S. Grant, D. T. Curiel, P. Dent, and P. B. Fisher. 2006. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol. Ther. 111: 596-628.
18. Jiang, H., Z. Z. Su, J. J. Lin, N. I. Goldstein, C. S. Young, and P. B. Fisher. 1996. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA 93: 9160-9165.
19. Soo, C., W. W. Shaw, E. Freymiller, M. T. Longaker, C. N. Bertolami, R. Chiu, A. Tieu, and K. Ting. 1999. Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. J. Cell Biochem. 74: 1-10.
20. Rachmilewitz, D. 1989. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br. Med. J. 298: 82-86.
21. Best, W. R., J. M. Becktel, and J. W. Singleton. 1979. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 77: 843-846.
22. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
23. Mahida, Y. R., J. Beltinger, S. Makh, M. Goke, T. Gray, D. K. Podolsky, and C. J. Hawkey. 1997. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am. J. Physiol. 273: G1341-G1348.
24. Okuno, T., A. Andoh, S. Bamba, Y. Araki, Y. Fujiyama, M. Fujiyama, and T. Bamba. 2002. Interleukin-1beta and tumor necrosis factor-α induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand. J. Gastroenterol. 37: 317-324.
25. Zweibaum, A., M. Pinto, G. Chevalier, E. Dussaulx, N. Triadou, B. Lacroix, K. Haffen, J. L. Brun, and M. Rousset. 1985. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J. Cell Physiol. 122: 21-29.
26. Rousset, M., M. Laburthe, M. Pinto, G. Chevalier, C. Rouyer-Fessard, E. Dussaulx, G. Trugnan, N. Boige, J. L. Brun, and A. Zweibaum. 1985. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J. Cell Physiol. 123: 377-385.
27. Kubens, B. S., and K. S. Zanker. 1998. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Cancer Lett. 131: 55-64.
28. Andoh, A., H. Takaya, T. Saotome, M. Shimada, K. Hata, Y. Araki, F. Nakamura, Y. Shintani, Y. Fujiyama, and T. Bamba. 2000. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 119: 211-219.
29. Xie, M. H., S. Aggarwal, W. H. Ho, J. Foster, Z. Zhang, J. Stinson, W. I. Wood, A. D. Goddard, and A. L. Gurney. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275: 31335-31339.
30. Gendler, S. J., C. A. Lancaster, J. Taylor-Papadimitriou, T. Duhig, N. Peat, J. Burchell, L. Pemberton, E. N. Lalani, and D. Wilson. 1990. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265: 15286-15293.
31. Gum, J. R., J. C. Byrd, J. W. Hicks, N. W. Toribara, D. T. Lamport, and Y. S. Kim. 1989. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J. Biol. Chem. 264: 6480-6487.
32. Gum, J. R., J. W. Hicks, D. M. Swallow, R. L. Lagace, J. C. Byrd, D. T. Lamport, B. Siddiki, and Y. S. Kim. 1990. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem. Biophys. Res. Commun. 171: 407-415.
33. Gross, M. S., V. Guyonnet-Duperat, N. Porchet, A. Bernheim, J. P. Aubert, and V. C. Nguyen. 1992. Mucin 4 (MUC4) gene: regional assignment (3q29) and RFLP analysis. Ann. Genet. 35: 21-26.
34. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
35. Shimada, M., A. Andoh, K. Hata, K. Tasaki, Y. Araki, Y. Fujiyama, and T. Bamba. 2002. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J. Immunol. 168: 861-868.
36. Madireddi, M. T., P. Dent, and P. B. Fisher. 2000. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. J. Cell Physiol. 185: 36-46.
37. Andoh, A., S. Fujino, S. Bamba, Y. Araki, T. Okuno, T. Bamba, and Y. Fujiyama. 2002. IL-17 selectively down-regulates TNF-α-induced RANTES gene expression in human colonic subepithelial myofibroblasts. J. Immunol. 169: 1683-1687.
38. Yasumoto, H., S. Kim, Y. Zhan, H. Miyazaki, M. Hoshiga, Y. Kaneda, R. Morishita, and H. Iwao. 2001. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Gene Ther. 8: 1682-1689.
39. Bamba, S., A. Andoh, H. Yasui, J. Makino, S. Kim, and Y. Fujiyama. 2003. Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1-and MAPK-dependent pathways. Am. J. Physiol. 285: G529-G538. (Pubitemid 37021812)
40. Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, et al. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984.
41. Hata, K., A. Andoh, M. Shimada, S. Fujino, S. Bamba, Y. Araki, T. Okuno, Y. Fujiyama, and T. Bamba. 2002. IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. 282: G1035-G1044.
42. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494.
43. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273: 18623-18632.
44. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364: 229-233.
45. Barr, R. K., T. S. Kendrick, and M. A. Bogoyevitch. 2002. Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277: 10987-10997.
46. Sugimoto, K., A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A. K. Bhan, R. S. Blumberg, R. J. Xavier, and A. Mizoguchi. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118: 534-544.
47. Chada, S., R. B. Sutton, S. Ekmekcioglu, J. Ellerhorst, J. B. Mumm, W. W. Leitner, H. Y. Yang, A. A. Sahin, K. K. Hunt, K. L. Fuson, et al. 2004. MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int. Immunopharmacol. 4: 649-667.
48. Sauane, M., R. V. Gopalkrishnan, D. Sarkar, Z. Z. Su, I. V. Lebedeva, P. Dent, S. Pestka, and P. B. Fisher. 2003. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14: 35-51.
49. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18: 4969-4980.
50. Dean, J. L., M. Brook, A. R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274: 264-269.
51. Murray, P. J. 2007. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178: 2623-2629.
52. Welte, T., S. S. Zhang, T. Wang, Z. Zhang, D. G. Hesslein, Z. Yin, A. Kano, Y. Iwamoto, E. Li, J. E. Craft, et al. 2003. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA 100: 1879-1884.
53. Tebbutt, N. C., A. S. Giraud, M. Inglese, B. Jenkins, P. Waring, F. J. Clay, S. Malki, B. M. Alderman, D. Grail, F. Hollande, J. K. Heath, and M. Ernst. 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8: 1089-1097.
54. Sugimoto, K. 2008. Role of STAT3 in inflammatory bowel disease. World J. Gastroenterol. 14: 5110-5114.
55. + T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20: 681-693.
56. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583-588.
57. Corfield, A. P., D. Carroll, N. Myerscough, and C. S. Probert. 2001. Mucins in the gastrointestinal tract in health and disease. Front Biosci. 6: D1321-D1357.
58. McGuckin, M. A., R. Eri, L. A. Simms, T. H. Florin, and G. Radford-Smith. 2009. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 15: 100-113.
59. van der Sluis, M., B. A. de Koning, A. C. de Bruijn, A. Velcich, J. P. Meijerink, J. B. van Goudoever, H. A. Buller, J. Dekker, I. van Seuningen, I. B. Renes, and A. W. Einerhand. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117-129.
60. An, G., B. Wei, B. Xia, J. M. McDaniel, T. Ju, R. D. Cummings, J. Braun, and L. Xia. 2007. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med. 204: 1417-1429.
61. Ho, S. B., L. A. Dvorak, R. E. Moor, A. C. Jacobson, M. R. Frey, J. Corredor, D. B. Polk, and L. L. Shekels. 2006. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 131: 1501-1517.
62. Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S. T. Eichhorst, J. M. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, et al. 2006. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. 290: G827-G838.
63. Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52: 1037-1046.
64. Seiderer, J., and S. Brand. 2009. IL-22: a two-headed cytokine in IBD? Inflamm. Bowel Dis. 15: 473-474.
65. Eager, R., L. Harle, and J. Nemunaitis. 2008. Ad-MDA-7; INGN 241: a review of preclinical and clinical experience. Expert. Opin. Biol. Ther. 8: 1633-1643.